| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |